Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Shandong Sinobioway Biomedicine's high P/S ratio and slower ...

Shandong Sinobioway Biomedicine's high P/S ratio and slower growth rate may pose a risk to its share price. Overvaluation and continuation of recent revenue trends could negatively impact the share price.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
1
+0
Translate
Report
1061 Views
Comment
Sign in to post a comment